Announce Date | 08/06/2024 |
EPS Normalized Actual | $1.56 (Beat by $0.07) |
EPS GAAP Actual | $1.56 (Beat by $0.07) |
Revenue Actual | $1.986B |
Revenue Surprise | Beat by $1986M |
Announce Date | 09/30/2024 (Pre-Market) |
EPS Normalized Estimate | $1.54141 |
EPS GAAP Estimate | $1.54141 |
Revenue Estimate | $4.302B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 8.37 | 21.92 | 8.25078 | 8.5459 | 4 |
Dec 2027 | 8.00012 | 22.94 | 7.88617 | 8.16825 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | 1.26 | 1.26 | 1.986B | 5.79% | 1986M |
FQ4 2021 (Dec 2021) | 0.88 | 0.88 | 1.967B | 8.13% | 1967M |
FQ3 2021 (Sep 2021) | 1.16 | 1.16 | 1.99B | 10.25% | 1990M |
FQ2 2021 (Jun 2021) | 1.08 | 1.08 | 1.948B | 20.53% | 1948M |
FQ1 2021 (Mar 2021) | 1.18 | 1.18 | 1.871B | 18.01% | 1871M |
FQ4 2020 (Dec 2020) | 0.75 | 0.75 | 1.807B | 7.36% | 1807M |
FQ3 2020 (Sep 2020) | 1.01 | 1.01 | 1.786B | 11.31% | 1786M |
FQ2 2020 (Jun 2020) | 0.79 | 0.79 | 1.548B | 0.06% | 1548M |
FQ4 Announce Date
09/30/2024 (Pre-Market)
Consensus EPS Estimates
1.54141
Consensus Revenue Estimates
4.302B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 1.7 | -- | 1.67982 | 1.71969 | 3 |
FQ3 2026 (Jul 2026) | 1.7 | -- | 1.67982 | 1.71969 | 5 |
FQ2 2026 (Jun 2026) | 1.86 | -- | 1.81799 | 1.9176 | 5 |
FQ1 2026 (Mar 2026) | 1.71 | -- | 1.67138 | 1.76296 | 3 |
FQ4 2025 (Oct 2025) | 1.62286 | -- | 1.6036 | 1.64166 | 4 |
FQ3 2025 (Jul 2025) | 1.63973 | -- | 1.62027 | 1.65873 | 6 |
FQ2 2025 (Jun 2025) | 1.66267 | -- | 1.62511 | 1.71416 | 6 |
FQ1 2025 (Mar 2025) | 1.49287 | -- | 1.45915 | 1.5391 | 4 |
FQ4 2024 (Oct 2024) | 1.48594 | -- | 1.47597 | 1.50589 | 8 |
FQ3 2024 (Sep 2024) | 1.54141 | -- | 1.51797 | 1.60588 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2026 (Oct 2026) | 2.57B | -- | 2.55B | 2.6B | 4 |
FQ3 2026 (Jul 2026) | 2.61B | -- | 2.58B | 2.63B | 5 |
FQ2 2026 (Jun 2026) | 2.64B | -- | 2.59B | 2.7B | 5 |
FQ1 2026 (Mar 2026) | 2.42B | -- | 2.38B | 2.48B | 6 |
FQ4 2025 (Oct 2025) | 2.44B | -- | 2.41B | 2.46B | 2 |
FQ3 2025 (Jul 2025) | 2.45B | -- | 2.43B | 2.47B | 2 |
FQ2 2025 (Jun 2025) | 2.47B | -- | 2.42B | 2.52B | 2 |
FQ1 2025 (Mar 2025) | 2.29B | -- | 2.25B | 2.34B | 2 |
FQ4 2024 (Oct 2024) | 2.3B | -- | 2.28B | 2.32B | 7 |
FQ3 2024 (Sep 2024) | 4.3B | -- | 3.96B | 4.65B | 12 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | 1.26 | 1.26 | 100% | |
FQ4 2021 (Dec 2021) | 0.88 | 0.88 | 100% | |
FQ3 2021 (Sep 2021) | 1.16 | 1.16 | 100% | |
FQ2 2021 (Jun 2021) | 1.08 | 1.08 | 100% | |
FQ1 2021 (Mar 2021) | 1.18 | 1.18 | 100% | |
FQ4 2020 (Dec 2020) | 0.75 | 0.75 | 100% | |
FQ3 2020 (Sep 2020) | 1.01 | 1.01 | 100% | |
FQ2 2020 (Jun 2020) | 0.79 | 0.79 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $1.99B | $1986M | 100% |
FQ4 2021 (Dec 2021) | $0B | $1.97B | $1967M | 100% |
FQ3 2021 (Sep 2021) | $0B | $1.99B | $1990M | 100% |
FQ2 2021 (Jun 2021) | $0B | $1.95B | $1948M | 100% |
FQ1 2021 (Mar 2021) | $0B | $1.87B | $1871M | 100% |
FQ4 2020 (Dec 2020) | $0B | $1.81B | $1807M | 100% |
FQ3 2020 (Sep 2020) | $0B | $1.79B | $1786M | 100% |
FQ2 2020 (Jun 2020) | $0B | $1.55B | $1548M | 100% |